Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.
Saved in:
| Title: | Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis. |
|---|---|
| Authors: | Hickey CL; Memorial University of Newfoundland, Division of Hematology, Newfoundland, Canada., Zhang MJ; Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, Wisconsin; CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin., Allbee-Johnson M; CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin., Romee R; Dana-Farber Cancer Institute, Division of Transplantation and Cellular Therapy, Boston, Massuchusetts., Majhail NS; Sarah Cannon Transplant and Cellular Therapy Network, Nashville, Tennessee., Malki MMA; City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, California., Antin JH; Dana-Farber Cancer Institute, Division of Transplantation and Cellular Therapy, Boston, Massuchusetts., Benjamin CL; University of Miami Miller School of Medicine, Department of Medicine, Miami, Florida., Bredeson C; Ottawa Hospital TCT Programme and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Chhabra S; Division of Hematology/Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ., Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina., Inamoto Y; Department of BMT & Cellular Therapy, Fujita Health University School of Medicine, Toyoake, Japan., Kanakry CG; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Milano F; Fred Hutchinson Cancer Center, Translational Science and Therapeutics Division, Seattle, Washington., Soiffer RJ; Dana Farber Institute, Division of Hematologic Malignancies, Boston, Massachusetts., Solomon SR; Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, Georgia., Spellman SR; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program (NMDP), Minneapolis, Minnesota., Brunstein CG; Cleveland Clinic, Taussig Cancer Institute, Department of Hematology and Oncology, Cleveland, Ohio., Cutler C; Dana-Farber Cancer Institute, Division of Transplantation and Cellular Therapy, Boston, Massuchusetts. Electronic address: corey_cutler@dfci.harvard.edu. |
| Source: | Transplantation and cellular therapy [Transplant Cell Ther] 2025 Mar; Vol. 31 (3), pp. 174.e1-174.e12. Date of Electronic Publication: 2025 Jan 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39755256 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hickey+CL%22">Hickey CL</searchLink>; Memorial University of Newfoundland, Division of Hematology, Newfoundland, Canada.<br /><searchLink fieldCode="AU" term="%22Zhang+MJ%22">Zhang MJ</searchLink>; Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, Wisconsin; CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin.<br /><searchLink fieldCode="AU" term="%22Allbee-Johnson+M%22">Allbee-Johnson M</searchLink>; CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin.<br /><searchLink fieldCode="AU" term="%22Romee+R%22">Romee R</searchLink>; Dana-Farber Cancer Institute, Division of Transplantation and Cellular Therapy, Boston, Massuchusetts.<br /><searchLink fieldCode="AU" term="%22Majhail+NS%22">Majhail NS</searchLink>; Sarah Cannon Transplant and Cellular Therapy Network, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Malki+MMA%22">Malki MMA</searchLink>; City of Hope, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, California.<br /><searchLink fieldCode="AU" term="%22Antin+JH%22">Antin JH</searchLink>; Dana-Farber Cancer Institute, Division of Transplantation and Cellular Therapy, Boston, Massuchusetts.<br /><searchLink fieldCode="AU" term="%22Benjamin+CL%22">Benjamin CL</searchLink>; University of Miami Miller School of Medicine, Department of Medicine, Miami, Florida.<br /><searchLink fieldCode="AU" term="%22Bredeson+C%22">Bredeson C</searchLink>; Ottawa Hospital TCT Programme and Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Chhabra+S%22">Chhabra S</searchLink>; Division of Hematology/Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, AZ.<br /><searchLink fieldCode="AU" term="%22Grunwald+MR%22">Grunwald MR</searchLink>; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.<br /><searchLink fieldCode="AU" term="%22Inamoto+Y%22">Inamoto Y</searchLink>; Department of BMT & Cellular Therapy, Fujita Health University School of Medicine, Toyoake, Japan.<br /><searchLink fieldCode="AU" term="%22Kanakry+CG%22">Kanakry CG</searchLink>; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Milano+F%22">Milano F</searchLink>; Fred Hutchinson Cancer Center, Translational Science and Therapeutics Division, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Soiffer+RJ%22">Soiffer RJ</searchLink>; Dana Farber Institute, Division of Hematologic Malignancies, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Solomon+SR%22">Solomon SR</searchLink>; Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Spellman+SR%22">Spellman SR</searchLink>; CIBMTR (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program (NMDP), Minneapolis, Minnesota.<br /><searchLink fieldCode="AU" term="%22Brunstein+CG%22">Brunstein CG</searchLink>; Cleveland Clinic, Taussig Cancer Institute, Department of Hematology and Oncology, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Cutler+C%22">Cutler C</searchLink>; Dana-Farber Cancer Institute, Division of Transplantation and Cellular Therapy, Boston, Massuchusetts. Electronic address: corey&#95;cutler@dfci.harvard.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101774629%22">Transplantation and cellular therapy</searchLink> [Transplant Cell Ther] 2025 Mar; Vol. 31 (3), pp. 174.e1-174.e12. <i>Date of Electronic Publication: </i>2025 Jan 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101774629 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-6367 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226666367%22">26666367 </searchLink><i>NLM ISO Abbreviation: </i>Transplant Cell Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39755256 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jtct.2024.12.021 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 174.e1-174.e12 Titles: – TitleFull: Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hickey CL – PersonEntity: Name: NameFull: Zhang MJ – PersonEntity: Name: NameFull: Allbee-Johnson M – PersonEntity: Name: NameFull: Romee R – PersonEntity: Name: NameFull: Majhail NS – PersonEntity: Name: NameFull: Malki MMA – PersonEntity: Name: NameFull: Antin JH – PersonEntity: Name: NameFull: Benjamin CL – PersonEntity: Name: NameFull: Bredeson C – PersonEntity: Name: NameFull: Chhabra S – PersonEntity: Name: NameFull: Grunwald MR – PersonEntity: Name: NameFull: Inamoto Y – PersonEntity: Name: NameFull: Kanakry CG – PersonEntity: Name: NameFull: Milano F – PersonEntity: Name: NameFull: Soiffer RJ – PersonEntity: Name: NameFull: Solomon SR – PersonEntity: Name: NameFull: Spellman SR – PersonEntity: Name: NameFull: Brunstein CG – PersonEntity: Name: NameFull: Cutler C IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2025 Mar Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2666-6367 Numbering: – Type: volume Value: 31 – Type: issue Value: 3 Titles: – TitleFull: Transplantation and cellular therapy Type: main |
| ResultId | 1 |
